Lpl Financial LLC Oncternal Therapeutics, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
BUY
$0.63 - $1.3 $23,310 - $48,100
37,000 Added 27.52%
171,459 $135,000
Q3 2022

Nov 14, 2022
BUY
$0.83 - $17.8 $63,910 - $1.37 Million
77,000 Added 134.01%
134,459 $120,000
Q1 2022

May 16, 2022
BUY
$1.37 - $2.43 $9,590 - $17,010
7,000 Added 13.87%
57,459 $80,000
Q4 2021

Feb 14, 2022
BUY
$2.27 - $4.39 $114,541 - $221,515
50,459 New
50,459 $115,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email